695 related articles for article (PubMed ID: 26934567)
1. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
; Stitziel NO; Stirrups KE; Masca NG; Erdmann J; Ferrario PG; König IR; Weeke PE; Webb TR; Auer PL; Schick UM; Lu Y; Zhang H; Dube MP; Goel A; Farrall M; Peloso GM; Won HH; Do R; van Iperen E; Kanoni S; Kruppa J; Mahajan A; Scott RA; Willenberg C; Braund PS; van Capelleveen JC; Doney AS; Donnelly LA; Asselta R; Merlini PA; Duga S; Marziliano N; Denny JC; Shaffer CM; El-Mokhtari NE; Franke A; Gottesman O; Heilmann S; Hengstenberg C; Hoffman P; Holmen OL; Hveem K; Jansson JH; Jöckel KH; Kessler T; Kriebel J; Laugwitz KL; Marouli E; Martinelli N; McCarthy MI; Van Zuydam NR; Meisinger C; Esko T; Mihailov E; Escher SA; Alver M; Moebus S; Morris AD; Müller-Nurasyid M; Nikpay M; Olivieri O; Lemieux Perreault LP; AlQarawi A; Robertson NR; Akinsanya KO; Reilly DF; Vogt TF; Yin W; Asselbergs FW; Kooperberg C; Jackson RD; Stahl E; Strauch K; Varga TV; Waldenberger M; Zeng L; Kraja AT; Liu C; Ehret GB; Newton-Cheh C; Chasman DI; Chowdhury R; Ferrario M; Ford I; Jukema JW; Kee F; Kuulasmaa K; Nordestgaard BG; Perola M; Saleheen D; Sattar N; Surendran P; Tregouet D; Young R; Howson JM; Butterworth AS; Danesh J; Ardissino D; Bottinger EP; Erbel R; Franks PW; Girelli D; Hall AS; Hovingh GK; Kastrati A; Lieb W; Meitinger T; Kraus WE; Shah SH; McPherson R; Orho-Melander M; Melander O; Metspalu A; Palmer CN; Peters A; Rader D; Reilly MP; Loos RJ; Reiner AP; Roden DM; Tardif JC; Thompson JR; Wareham NJ; Watkins H; Willer CJ; Kathiresan S; Deloukas P; Samani NJ; Schunkert H
N Engl J Med; 2016 Mar; 374(12):1134-44. PubMed ID: 26934567
[TBL] [Abstract][Full Text] [Related]
2. Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.
Dewey FE; Gusarova V; O'Dushlaine C; Gottesman O; Trejos J; Hunt C; Van Hout CV; Habegger L; Buckler D; Lai KM; Leader JB; Murray MF; Ritchie MD; Kirchner HL; Ledbetter DH; Penn J; Lopez A; Borecki IB; Overton JD; Reid JG; Carey DJ; Murphy AJ; Yancopoulos GD; Baras A; Gromada J; Shuldiner AR
N Engl J Med; 2016 Mar; 374(12):1123-33. PubMed ID: 26933753
[TBL] [Abstract][Full Text] [Related]
3. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial.
Smart-Halajko MC; Kelley-Hedgepeth A; Montefusco MC; Cooper JA; Kopin A; McCaffrey JM; Balasubramanyam A; Pownall HJ; Nathan DM; Peter I; Talmud PJ; Huggins GS;
BMC Med Genet; 2011 Jun; 12():89. PubMed ID: 21714923
[TBL] [Abstract][Full Text] [Related]
4. Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes.
Lotta LA; Stewart ID; Sharp SJ; Day FR; Burgess S; Luan J; Bowker N; Cai L; Li C; Wittemans LBL; Kerrison ND; Khaw KT; McCarthy MI; O'Rahilly S; Scott RA; Savage DB; Perry JRB; Langenberg C; Wareham NJ
JAMA Cardiol; 2018 Oct; 3(10):957-966. PubMed ID: 30326043
[TBL] [Abstract][Full Text] [Related]
5. Impact of loss-of-function in angiopoietin-like 4 on the human phenome.
Gagnon E; Bourgault J; Gobeil É; Thériault S; Arsenault BJ
Atherosclerosis; 2024 Jun; 393():117558. PubMed ID: 38703417
[TBL] [Abstract][Full Text] [Related]
6. Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
Khera AV; Won HH; Peloso GM; O'Dushlaine C; Liu D; Stitziel NO; Natarajan P; Nomura A; Emdin CA; Gupta N; Borecki IB; Asselta R; Duga S; Merlini PA; Correa A; Kessler T; Wilson JG; Bown MJ; Hall AS; Braund PS; Carey DJ; Murray MF; Kirchner HL; Leader JB; Lavage DR; Manus JN; Hartzel DN; Samani NJ; Schunkert H; Marrugat J; Elosua R; McPherson R; Farrall M; Watkins H; Lander ES; Rader DJ; Danesh J; Ardissino D; Gabriel S; Willer C; Abecasis GR; Saleheen D; Dewey FE; Kathiresan S;
JAMA; 2017 Mar; 317(9):937-946. PubMed ID: 28267856
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
[TBL] [Abstract][Full Text] [Related]
8. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in Type 2 diabetic Tunisian population.
Abid K; Trimeche T; Mili D; Msolli MA; Trabelsi I; Nouira S; Kenani A
Lipids Health Dis; 2016 Mar; 15():63. PubMed ID: 27004807
[TBL] [Abstract][Full Text] [Related]
9. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
[TBL] [Abstract][Full Text] [Related]
10. Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease.
Biterova E; Esmaeeli M; Alanen HI; Saaranen M; Ruddock LW
Sci Rep; 2018 Apr; 8(1):6752. PubMed ID: 29713054
[TBL] [Abstract][Full Text] [Related]
11. The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk.
Smart-Halajko MC; Robciuc MR; Cooper JA; Jauhiainen M; Kumari M; Kivimaki M; Khaw KT; Boekholdt SM; Wareham NJ; Gaunt TR; Day IN; Braund PS; Nelson CP; Hall AS; Samani NJ; Humphries SE; Ehnholm C; Talmud PJ
Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2277-82. PubMed ID: 20829508
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in ANGPTL4 provides insights into protein processing and function.
Yin W; Romeo S; Chang S; Grishin NV; Hobbs HH; Cohen JC
J Biol Chem; 2009 May; 284(19):13213-22. PubMed ID: 19270337
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal changes in triglycerides according to ANGPTL4[E40K] genotype and longitudinal body weight change in the atherosclerosis risk in communities study.
Nettleton JA; Volcik KA; Demerath EW; Boerwinkle E; Folsom AR
Ann Epidemiol; 2008 Nov; 18(11):842-6. PubMed ID: 18809343
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate intake modifies associations between ANGPTL4[E40K] genotype and HDL-cholesterol concentrations in White men from the Atherosclerosis Risk in Communities (ARIC) study.
Nettleton JA; Volcik KA; Hoogeveen RC; Boerwinkle E
Atherosclerosis; 2009 Mar; 203(1):214-20. PubMed ID: 18599063
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.
Lei X; Shi F; Basu D; Huq A; Routhier S; Day R; Jin W
J Biol Chem; 2011 May; 286(18):15747-56. PubMed ID: 21398697
[TBL] [Abstract][Full Text] [Related]
16. The Genetics of Dyslipidemia--When Less Is More.
Kersten S
N Engl J Med; 2016 Mar; 374(12):1192-3. PubMed ID: 26934667
[No Abstract] [Full Text] [Related]
17. Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography.
Moennig G; Wiebusch H; Enbergs A; Dorszewski A; Kerber S; Schulte H; Vielhauer C; Haverkamp W; Assmann G; Breithardt G; Funke H
Atherosclerosis; 2000 Apr; 149(2):395-401. PubMed ID: 10729390
[TBL] [Abstract][Full Text] [Related]
18. Characterization of sexual dimorphism in ANGPTL4 levels and function.
Deng M; Kersten S
J Lipid Res; 2024 Apr; 65(4):100526. PubMed ID: 38431115
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.
Dijk W; Beigneux AP; Larsson M; Bensadoun A; Young SG; Kersten S
J Lipid Res; 2016 Sep; 57(9):1670-83. PubMed ID: 27034464
[TBL] [Abstract][Full Text] [Related]
20. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization.
Yau MH; Wang Y; Lam KS; Zhang J; Wu D; Xu A
J Biol Chem; 2009 May; 284(18):11942-52. PubMed ID: 19246456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
